What is it about?
Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) has become an important therapeutic option in pediatric patients with extensive or refractory abdominal tumors. This aggressive treatment is complex, not only regarding surgical technique, but also regarding anesthetic management. We present the anesthetic management and postoperative pain control strategies for pediatric CRS-HIPEC utilizing a novel protocol.
Photo by National Cancer Institute on Unsplash
Why is it important?
This is the largest case series on the anesthetic, fluid, and pain management of pediatric CRS-HIPEC ever reported. Utilizing a novel anesthetic and post operative pain management protocol, we were able to avoid the need for postoperative intubation, allow for early ambulation, and minimize both intraoperative and postoperative opioid requirements. This is a major advancement for the management of this complex surgical procedure.
Read the Original
This page is a summary of: Anesthesia and pain management of pediatric cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, Pediatric Anesthesia, September 2022, Wiley, DOI: 10.1111/pan.14551.
You can read the full text:
The following have contributed to this page